中英科技(300936.SZ):擬終止重大資產重組事項
格隆匯12月20日丨中英科技(300936.SZ)公佈,2024年12月19日,常州中英科技股份有限公司收到蘇州博特蒙電機有限公司(以下簡稱“標的公司”或“博特蒙”)及交易對手吳志民、蘇州博域研科技有限公司、蘇州騰馬一號創業投資合夥企業(有限合夥)、張韓亮發出的《關於終止股權收購事項的協商函》,由於股權收購事項歷時較長,市場環境較股權收購交易籌劃之初發生較大變化,各方經過多輪談判,目前尚未能就交易方案中的核心條款達成一致意見。交易各方擬終止本次股權收購事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.